The treatment of resistant hypertension has received a boost with the recent US Food and Drug Administration (FDA) approval of a completely new therapeutic approach that reduces activity in the ...

In June 2026, Medtronic drew attention as analysts emphasized its positioning in cardiac ablation, diabetes care and ...

PARIS, France—With renal denervation on the cusp of gaining a place in clinical practice for the treatment of hypertension, researchers are looking more closely at other conditions associated with ...

SAN DIEGO, CA—A sham-controlled, pilot study of the Vessix renal denervation system (Boston Scientific) failed to replicate the positive results seen over the past year from similarly designed studies ...

PARIS — Renal denervation using ultrasound rather than radiofrequency ablation significantly reduced ambulatory blood pressure (BP) in the absence of antihypertensive agents compared with a sham ...

Compared with previous surgical iterations of the procedure, explains Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, Mount Sinai Fuster Heart Hospital, newer and FDA-approved catheter-based ...

The Society for Cardiovascular Angiography and Interventions (SCAI) has released a proceedings document outlining the possible role of renal denervation (RDN) as a therapeutic option to complement ...

In this communication we report the results of a renewed inquiry into the role of the nervous system on the course of experimental hemorrhagic or endotoxic shock. Data showing that denervation of the ...

Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases has announced the first patient treated in its pivotal randomized trial of dNerva® targeted lung denervation ...